Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 27.9 |
| Revenue growth | | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 29.9 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | -1.9 |
| Gross margin | | | | | -6.9% |
| Research and development | 89.8 | 71.4 | 53.9 | 24.3 | |
| General and administrative | 37.4 | 29.3 | 12.7 | 4.0 | 1.9 |
| EBIT | -127.2 | -100.8 | -66.7 | -28.3 | -29.9 |
| EBIT margin | | | | | -106.9% |
| Pre-tax income | -126.3 | -100.3 | -66.6 | -28.0 | -29.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -126.3 | -100.3 | -66.6 | -28.0 | -29.9 |
| Net margin | | | | | -106.9% |
| |
| Diluted EPS | ($3.25) | ($2.67) | ($2.91) | ($3.81) | ($4.08) |
| Shares outstanding (diluted) | 38.8 | 37.6 | 22.9 | 7.4 | 7.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|